Eckelman Living Trust Dated February 5, 2014, 10% Owner, Chief Scientific Officer at Inhibrx, Inc. (INBX), sold 17,000 shares at $25.90 ($440K) on 2021-02-16, disclosed to the SEC on 2021-02-18.
Open-market sale of $440k INBX by 10% Owner, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| INBX | SELL | 2022-04-07 | $10K | — | Filing → |